Radiobiological comparison between Cobalt‐60 and Iridium‐192 high‐dose‐rate brachytherapy sources: Part I—cervical cancer

Purpose This study aimed to compare the biological effective doses (BEDs) to clinical target volume (CTV) and organs at risk (OARs) for cervical cancer patients treated with high‐dose‐rate (HDR) Iridium‐192 (192Ir) or Cobalt‐60 (60Co) brachytherapy (BT) boost and to determine if the radiobiological...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medical physics (Lancaster) 2021-10, Vol.48 (10), p.6213-6225
Hauptverfasser:	Dayyani, Mahdieh, Hoseinian‐Azghadi, Elie, Miri‐Hakimabad, Hashem, Rafat‐Motavalli, Laleh, Abdollahi, Sara, Mohammadi, Najmeh
Format:	Artikel
Sprache:	eng
Schlagworte:	brachytherapy boost cervical cancer high‐dose‐rate brachytherapy radiobiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!